Global Drug Testing Market

Drug Testing Market Size, Share, Growth Analysis, By Product Type(Analytical Instruments, Rapid Testing Devices), By Sample Type(Urine, Breath), By End User(Hospitals, Workplace) - Industry Forecast 2024-2031


Report ID: SQMIG35D2032 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 92 | Figures: 76

Drug Testing Market Insights

Drug Testing Market size was valued at USD 5.13 billion in 2019 and is poised to grow from USD 5.6 billion in 2023 to USD 10.3 billion by 2031, growing at a CAGR of 9.1% in the forecast period (2024-2031).

The process of detecting illicit and some prescribed medications in blood, urine, and other biological samples is known as drug testing. A drug testing method is also known as the analysis and detection of performance-enhancing substances (such as steroids and HGH) used by professional athletes to boost stamina and performance during competition. Government agencies' stringent rules demanding alcohol and drug testing for safety concerns, as well as increased activities to monitor and prevent substance addiction, are expected to boost market growth. Furthermore, the rising prevalence of substance misuse around the world has increased the necessity for screening, fueling the demand for drug testing. Furthermore, the COVID-19 epidemic and the associated business closures, economic slowdown, and job losses have harmed people's mental health and contributed to increasing rates of substance usage.

US Drug Testing Market is poised to grow at a sustainable CAGR for the next forecast year.

Market snapshot - 2024-2031

Global Market Size

USD 5.13 billion

Largest Segment

Hospitals

Fastest Growth

Hospitals

Growth Rate

9.1% CAGR

Global Drug Testing Market 2021-2028 ($ Mn)
Country Share for North America Region- 2021 (%)
Global Drug Testing Market Size by End User 2021-2028 ($ Mn)
Global Drug Testing Market Size by End User 2021-2028 (%)

To get more reports on the above market click here to Buy The Report

Drug Testing Market Segmental Analysis

The global drug testing market is segmented based on product type, sample type, end user, and region. Based on the product type, the market is segmented into analytical instruments, rapid testing devices, and consumables. Based on the sample type, the market is segmented into urine, breath, oral fluids, others. Based on the end user, the market is segmented into hospitals, workplace, criminal justice, laboratories. Based on the region it is categorized into North America, Europe, Asia-Pacific, South America, and MEA.

Drug Testing Market Analysis by Product Type

Based on the product type, the market is segmented into analytical instruments, rapid testing devices, and consumables. Among these, the consumables segment of the market is projected to hold the most substantial market share. The increased availability of modern consumables that offer enhanced solutions for making testing simple, precise, and quick has propelled market expansion. For example, at the 2019 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting in August 2019, MedTest Dx, Inc. launched Clinitox Calibrators and Controls. These calibrators and controls perform confirmation testing for laboratories in order to reduce the need for step measurement and management of controls and certifications, as well as the necessity to purchase and set-up materials and multiple handling. This thus is projected to contribute to the segmental growth of the market in the upcoming years.

Global Drug Testing Market By End User, 2021 (%), 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Drug Testing Market Regional Insights

In 2021, North America is expected to have the biggest market share. The North American market's dominance is attributed to factors such as rising illicit drug consumption, the availability of government funding to combat drug abuse, laws supporting drug screening, the rising burden of accidents caused by alcohol impairment, and the presence of key players in the region, all of which are driving the growth of the drug testing market in this region. Certain factors, such as an increase in the number of drug and alcohol misuse cases and the strict enforcement of regulations. New organ-on-a-chip technologies provide more precise and accurate perception of pharmacological effects on the human body. Organ-on-a-chip advancements are also contributing to the expansion of the North American drug testing market.

Global Drug Testing Market By Geography, 2021 - 2028, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Drug Testing Market Dynamics

Drug Testing Market Driver

  • The key factor that drives the growth of the market is growing drugs and alcohol consumption. Drug and alcohol abuse are on the rise all around the world. According to the World Drug Report 2021, an estimated 275 million persons worldwide aged 15-64, or one in every 18 in that age group, used drugs at least once in the preceding year in 2019 (range: 175 million to 374 million). Drug use problems were expected to affect 36.3 million people, or over 13% of the global population, in 2019. In the same year, drug use killed about 500,000 people, while drug use disorders resulted in the loss of 18 million years of healthy life, primarily owing to opioids. Similar increases in alcohol intake have been observed, with the result being an increase in the prevalence of impaired driving. The increased consumption of illicit substances and alcohol will drive the development of drug screening goods and services on the road, consequently boosting market growth overall.

Drug Testing Market Restraint

  • Prohibition on workplace drug testing in some countries is projected to restrain the market growth. Some countries, including Canada, Colombia, Argentina, Chile, and South Africa, regard workplace drug and alcohol testing to be a violation of employee privacy. In France, for example, pre-employment drug testing is only undertaken when physicians prescribe it. Drug and alcohol testing in the workplace is illegal in Poland and the Czech Republic. Eastern Canadian case rules allow drug and alcohol testing only when occupational operations are fundamentally risky or when drug and alcohol testing is limited to a few unique instances. Such bans in certain nations may impede the adoption of drug and alcohol testing in these markets, hence limiting total market growth.

Request Free Customization of this report to help us to meet your business objectives.

Drug Testing Market Competitive Landscape

The market is fragmented in nature. The prominent players operating in the market are constantly adopting various growth strategies in order to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D in order to supply industries with the most efficient and cost-effective solutions.

Top Players in the Global Drug Testing Market

  • Quest Diagnostics
  • LabCorp
  • Alere
  • Thermo Fisher Scientific
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthcare GmbH
  • Bio-Rad Laboratories, Inc.
  • Express Diagnostics Int'l, Inc.
  • Drägerwerk AG & Co. KGaA
  • Shimadzu Corporation
  • Biomedical Diagnostics
  • Randox Laboratories Ltd.
  • MPD, Inc.
  • Cannabix Technologies Inc.
  • BioMérieux SA
  • Psychemedics Corporation
  • CRL Inc.
  • Sonic Healthcare
  • Omega Laboratories, Inc.

Drug Testing Market Recent Developments

  • In August 2021, Quest Diagnostics and Select Health of South Carolina have agreed to extend Select Health's laboratory network for Medicaid and Medicare-Medicaid dual-eligible enrollees, as well as to improve member access to diagnostics information services.

Drug Testing Key Market Trends

  • Fingerprint-based drug testing is a new concept that has gained traction as a result of the COVID-19 pandemic. The coronavirus has made drug testing in hospitals, labs, and other facilities problematic due to the danger of viral transmission. Although fingerprint-based drug screening can help prevent the spread of COVID, it is noninvasive, portable, less time-consuming, hygienic, allows for social distancing, is user-friendly, and does not necessitate any special preparation for sample collection and processing. This test is simple to administer whenever and wherever it is needed, providing flexible and effective workplace drug testing. To detect drugs and drug metabolites, the test analyses microscopic traces of sweat in the fingerprint. This test is utilized in the workplace, criminal justice, law enforcement, and drug treatment program. To detect drugs and drug metabolites, the test analyses microscopic traces of sweat in the fingerprint. If extensively used, this test is projected to replace urine, hair, and blood-based drug tests. This is a big opportunity for market participants in the drug screening sector to capitalize on.

Drug Testing Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.

According to our analysis, the global drug testing market is segmented based on product type, sample type, end user, and region. Based on the product type, the consumables segment of the market is projected to hold the most substantial share in the market. Based on the sample type, the breath segment of the market is projected to hold the most substantial share in the market. Based on the end user, the hospitals segment of the market is projected to hold the most substantial share in the market.

Report Metric Details
Market size value in 2023 USD 5.13 billion
Market size value in 2031 USD 10.3 billion
Growth Rate 9.1%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Product Type
    • Analytical Instruments, Rapid Testing Devices, Consumables
  • Sample Type
    • Urine, Breath, Oral Fluids, Others
  • End User
    • Hospitals, Workplace, Criminal Justice, Laboratories
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Quest Diagnostics
  • LabCorp
  • Alere
  • Thermo Fisher Scientific
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthcare GmbH
  • Bio-Rad Laboratories, Inc.
  • Express Diagnostics Int'l, Inc.
  • Drägerwerk AG & Co. KGaA
  • Shimadzu Corporation
  • Biomedical Diagnostics
  • Randox Laboratories Ltd.
  • MPD, Inc.
  • Cannabix Technologies Inc.
  • BioMérieux SA
  • Psychemedics Corporation
  • CRL Inc.
  • Sonic Healthcare
  • Omega Laboratories, Inc.
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

Historical Year 2019

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Drug Testing Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Drug Testing Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Drug Testing Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Drug Testing Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Drug Testing Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Drug Testing Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Drug Testing Market size was valued at USD 5.13 billion in 2019 and is poised to grow from USD 5.6 billion in 2023 to USD 10.3 billion by 2031, growing at a CAGR of 9.1% in the forecast period (2024-2031).

The market is fragmented in nature. The prominent players operating in the market are constantly adopting various growth strategies in order to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D in order to supply industries with the most efficient and cost-effective solutions. 'Quest Diagnostics', 'LabCorp', 'Alere', 'Thermo Fisher Scientific', 'Abbott Laboratories', 'F. Hoffmann-La Roche Ltd', 'Siemens Healthcare GmbH', 'Bio-Rad Laboratories, Inc.', 'Express Diagnostics Int'l, Inc.', 'Drägerwerk AG & Co. KGaA', 'Shimadzu Corporation', 'Biomedical Diagnostics', 'Randox Laboratories Ltd.', 'MPD, Inc.', 'Cannabix Technologies Inc.', 'BioMérieux SA', 'Psychemedics Corporation', 'CRL Inc.', 'Sonic Healthcare', 'Omega Laboratories, Inc.'

The key factor that drives the growth of the market is growing drugs and alcohol consumption. Drug and alcohol abuse are on the rise all around the world. According to the World Drug Report 2021, an estimated 275 million persons worldwide aged 15-64, or one in every 18 in that age group, used drugs at least once in the preceding year in 2019 (range: 175 million to 374 million). Drug use problems were expected to affect 36.3 million people, or over 13% of the population, in 2019. In the same year, drug use killed about 500,000 people, while drug use disorders resulted in the loss of 18 million years of healthy life, primarily owing to opioids. Similar increases in alcohol intake have been observed, with the result being an increase in the prevalence of impaired driving. The increased consumption of illicit substances and alcohol will drive the development of drug screening goods and services on the road, consequently boosting market growth overall.

Fingerprint-based drug testing is a new concept that has gained traction as a result of the COVID-19 pandemic. The coronavirus has made drug testing in hospitals, labs, and other facilities problematic due to the danger of viral transmission. Although fingerprint-based drug screening can help prevent the spread of COVID, it is noninvasive, portable, less time-consuming, hygienic, allows for social distancing, is user-friendly, and does not necessitate any special preparation for sample collection and processing. This test is simple to administer whenever and wherever it is needed, providing flexible and effective workplace drug testing. To detect drugs and drug metabolites, the test analyses microscopic traces of sweat in the fingerprint. This test is utilized in the workplace, criminal justice, law enforcement, and drug treatment program. To detect drugs and drug metabolites, the test analyses microscopic traces of sweat in the fingerprint. If extensively used, this test is projected to replace urine, hair, and blood-based drug tests. This is a big opportunity for market participants in the drug screening sector to capitalize on.

In 2021, North America is expected to have the biggest market share. The North American market's dominance is attributed to factors such as rising illicit drug consumption, the availability of government funding to combat drug abuse, laws supporting drug screening, the rising burden of accidents caused by alcohol impairment, and the presence of key players in the region, all of which are driving the growth of the drug testing market in this region. Certain factors, such as an increase in the number of drug and alcohol misuse cases and the strict enforcement of regulations. New organ-on-a-chip technologies provide more precise and accurate perception of pharmacological effects on the human body. Organ-on-a-chip advancements are also contributing to the expansion of the North American drug testing market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Drug Testing Market

Product ID: SQMIG35D2032

$5,300
BUY NOW GET FREE SAMPLE